logo_desma

News

banner_tool-acquisition.png

Press release SIT - SANOFI

SIT Laboratorio Farmaceutico (hereafter “SIT”) is pleased to announce the acquisition of established product SULMETIN from Sanofi, as a result of the agreement signed on November 8, 2022.
banner_tool-acquisition.png

Press release SIT - SANOFI

SIT Laboratorio Farmaceutico (hereafter “SIT”) is pleased to announce the acquisition of Potasion brand from Sanofi, as a result of the agreement signed on November 8, 2022.
banner_tool-acquisition.png

Press release SIT - BIAL

SIT Laboratorio Farmaceutico (hereafter “SIT”) is pleased to announce the acquisition of Natifar and Natimed brands from Laboratorios BIAL, S.A, a Spanish affiliate of BIAL Group (BIAL), as a result of the agreement signed on October 25th, 2022.
banner_tool-acquisition.png

SIT Laboratorio Farmaceutico a company of DESMA HC Group Acquires LOPRESSOR, ICAZ and MIOREL from Daiichi Sankyo France

Daiichi Sankyo France and SIT Laboratorio Farmaceutico (DESMA HC Group) are pleased to announce the acquisition of LOPRESSOR, ICAZ and MIOREL by SIT Laboratorio Farmaceutico from Daiichi Sankyo France.
Lamberto-Pedrotti.jpg

A passion for pharmaceuticals

The magazine European Business interviews the Board of Directors Adviser Lamberto Pedrotti
sostenGO.jpg

#sostenGO (support) women and entrepreneurship

#sostenGO is an initiative by which Laboratorio Farmaceutico SIT is constantly promoting and rewarding female entrepreneurship.